Back to search

Vector Bioscience Cambridge Ltd

13564111

active
ltd
england wales
Companies House
Health Score
80 / 100

Healthy

30/30
Filing
10/30
Financial
40/40
Risk
  • Going concern doubt noted in accounts (-10)

Details

20-22 Wenlock Road, London, N1 7GU
Incorporated 13/08/2021

Compliance

Last accounts

31/08/2025

total exemption full

Next accounts due

31/05/2027

On track

Confirmation statement

Last: 12/08/2026

Due 26/08/2027

On track

Industry

72110
Research and experimental development on biotechnology

Officers

Mr Jogchum Brinksma

director · Since 13/08/2021

COMPANY DIRECTOR

DUTCH · UNITED KINGDOM · Age 57

Dr David Fairen-Jimenez

director · Since 13/08/2021

COMPANY DIRECTOR

SPANISH · UNITED KINGDOM · Age 46

Also on 1 other board

Ms Lluna Gallego Segrelles

director · Since 13/08/2021

COMPANY DIRECTOR

SPANISH · UNITED KINGDOM · Age 45

Jogchum Brinksma

director · Since 13/08/2021

Dutch · United Kingdom · Age 57

David Fairen-Jimenez

director · Since 13/08/2021

Spanish · United Kingdom · Age 46

Lluna Gallego Segrelles

director · Since 13/08/2021

Spanish · United Kingdom · Age 45

Persons with Significant Control

Ms Lluna Gallego Segrelles

25–50% shares

Spanish · United Kingdom · Age 45

20-22, Wenlock Road, London, N1 7GU

Notified 13/08/2021

Dr David Fairen-Jimenez

25–50% shares

Spanish · United Kingdom · Age 46

20-22, Wenlock Road, London, N1 7GU

Notified 13/08/2021

Former PSCs

Mr Jogchum Brinksma

Ceased 21/08/2024

Change History

officer appointedBRINKSMA, Jogchum
2026-07-25
officer appointedFAIREN-JIMENEZ, David, Dr
2026-07-25
officer appointedGALLEGO SEGRELLES, Lluna
2026-07-25
statusactive
2026-07-25

Active

typeltd
2026-07-25

Private Limited Company

address line120-22 Wenlock Road
2026-07-25

20-22 WENLOCK ROAD

post townLondon
2026-07-25

LONDON

CompanyRankvs 729+ SIC 72110 peers
62

Financial strength86th percentile among SIC peers · 22/25
Employees91th percentile among SIC peers · 14/15
LiquidityCurrent ratio 1.71× · 16/20
Longevity5 years trading (max 15) · 5/15
Filing complianceAll filings up to date · 15/15
Going concern doubt -10
Show leaderboard
How is this score calculated?
Financial strength22/25 pts

Net worth compared to all companies in the same SIC code with published accounts. Top quartile earns the full 25 points.

Employees14/15 pts

Workforce size relative to sector peers from the most recent accounts. A larger team generally signals commercial scale.

Liquidity16/20 pts

Current assets ÷ current liabilities. A ratio above 2× earns full marks; between 1–2× scores partially; below 0.5× scores minimal points.

Longevity5/15 pts

One point per year of operation since incorporation, capped at 15. Older companies have a proven track record.

Filing compliance15/15 pts

Full 15 points when both annual accounts and confirmation statement are filed on time. Points are deducted for each overdue filing.

Risk deductions

Going concern doubt: -10 pts

Maximum score is 100. Deductions apply for insolvency history, outstanding charges, going concern doubt, or disqualified officers.

Going Concern Doubt

Act 2006. The financial statements are prepared in sterling, which is the functional currency of the company. Monetary amounts in these financial statements are rounded to the nearest £. 2.2. Going Concern Disclosure The directors have not identified any material uncertainties related to events or conditions that may cast significant doubt about the company's ability to continue as a going concern

Key FinancialsYear ending 31/08/2025

Net Worth

£255k

Balance sheet strength

Cash

£265k

Cash in the bank

Net Current Assets

£228k

Working capital

Current Assets

£548k

Current Liabilities

£320k

Fixed Assets

£27k

Debtors

£283k

9avg. employees+3

Director Loans(2024)

Company owes directors£10k

Balance Sheet

Intangible assets£23k
Assets less current liabilities£255k
Signed by Ms Lluna Gallego Segrelles 20 August 2026Prepared with Acorah Software Products - Accounts Production

EstimatesDerived

YearCurrent RatioImplied Profit
20251.71+£221k
20241.00+£49k
20230.91

Derived from filed accounts. Not audited figures.